XTL Biopharmaceuticals Ltd.

XTLB·NasdaqCM·Healthcare
Compare
1.7000−0.0250 (−1.45%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.7250
Open1.7600
Day range1.61011.8000
52-week range1.60005.6400
Off day high−5.56%
Off 52-week high−69.86%
Volume9.53K
Avg. volume (3M)8.08K
Market cap4.18M
EPS (TTM)-0.3600
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.47
Shares outstanding2.46M
Short interest0.23% of float
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
XTLB AIM XBIO GTBP XLO XBIT
Market cap 4.18M 6.42M 4.71M 9.98M 57.31M 59.45M
P/E (TTM) — — — — — —
Forward P/E — -0.4 -3.0 -0.4 -15.0 15.0
Price/book — 0.6 0.8 2.4 0.8 0.5
Dividend yield — — — — — —
1-year change −58.81% −90.12% −24.91% −65.44% −25.22% −6.13%
Today −1.45% +0.19% −3.37% −8.16% +0.35% −2.01%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All XTLB news ›

No recent coverage in the 4Search index.

From the 4Search news index, newest first.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance